SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRtw Biotech Regulatory News (RTW)

Share Price Information for Rtw Biotech (RTW)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
2.19
Ask:
2.21
Spread: 0.02 (0.913%)
Market Cap: $714.60m
RTW Live PriceLast checked at - London Stock Exchange

Intraday Rtw Biotech Share Chart

Director Declaration

31 May 2024 12:00

RNS Number : 6721Q
RTW Biotech Opportunities Ltd
31 May 2024
 

LEI: 549300Q7EXQQH6KF7Z84

31 May 2024

RTW Biotech Opportunities Ltd (the "Company")

Director Declaration

In accordance with LR 9.6.14, the Company announces that Paul Le Page, a non-executive director of the Company, will join the board of Sequoia Economic Infrastructure Income Fund Limited, as a non-executive director with effect from 7 June 2024.

For Further Information:

 

RTW Investments, LP

+44 (0)20 7959 6361

biotechopportunities@rtwfunds.com

Woody Stileman, Managing Director

Krisha McCune, Director, Investor Relations

 

 

 

 

About RTW Biotech Opportunities Ltd:

RTW Biotech Opportunities Ltd (LSE: RTW & RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities Ltd invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives. RTW Biotech Opportunities Ltd is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.

Visit the website at www.rtwfunds.com/rtw-biotech-opportunities-ltd for more information

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNBGGDURGXDGSB
Date   Source Headline
14th Aug 20257:00 amRNSMonthly Valuation Update and Factsheet
17th Jul 20257:00 amRNSUpdate on Kailera Therapeutics
15th Jul 20257:00 amRNSMonthly Valuation Update and Factsheet
10th Jul 20257:00 amRNSMerck to acquire Verona Pharma
3rd Jul 20255:34 pmRNSHolding(s) in Company
1st Jul 20257:00 amRNSTotal Voting Rights
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:01 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSUpdate on Corxel Pharmaceuticals
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:01 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSMonthly Valuation Update and Factsheet
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20254:00 pmRNSResult of AGM
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 202511:00 amRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20257:01 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:01 amRNSTransaction in Own Shares
30th May 20257:00 amRNSPortfolio Updates
29th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSUpdate on Rocket Pharmaceuticals
16th May 20257:00 amRNSNotice of AGM
14th May 20257:01 amRNSTransaction in Own Shares
14th May 20257:00 amRNSMonthly Valuation Update and Factsheet
13th May 20257:00 amRNSTransaction in Own Shares
12th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares
2nd May 20257:00 amRNSUpdate on Artios Pharma
1st May 20257:01 amRNSTotal Voting Rights
1st May 20257:00 amRNSTransaction in Own Shares
30th Apr 20257:01 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.